ATLANTA, April 8, 2025 /PRNewswire/ -- ArtBlood, a biotechnology company specializing in transfusion blood production, announced that it has signed a Memorandum of Understanding (MOU) with Expression ...
Scientists have been working on the artificial production of blood for several decades. Now, researchers from the University of Konstanz and Queen Mary University of London have taken an important ...
Scorpius Holdings, Inc. has announced a collaboration with KaloCyte to improve the manufacturing efficiency of KaloCyte's lead product, ErythroMer™, a bio-engineered artificial red blood cell designed ...
The successes seen in a number of clinical studies on viral vector-based gene therapies (AAV, retroviral, and lentiviral vectors) are well documented, with an ever-broadening pipeline of products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback